Parag Phoolchand Saxena is an Indian entrepreneur and businessperson who founded 6 companies, including: Eucrates Biomedical Acquisition Corp., Vedanta Capital LLC and New Silk Route Partners LLC and who has been the head of 8 different companies. Currently, he holds the position of Chairman for Reviva Pharmaceuticals Holdings, Inc., Chief Executive Officer & Founding General Partner at New Silk Route Partners LLC (which he founded in 2010), Chief Executive Officer & Managing Partner at New Silk Route Advisors LP (which he founded in 2006) (a subsidiary of New Silk Route Partners LLC), Chief Executive Officer & Director at Eucrates Biomedical Acquisition Corp. (which he founded in 2020) and General Partner for Vedanta Capital LLC (which he founded in 2006), Chief Executive Officer & Managing Partner at Vedanta Management LP (which he founded in 2006) (a subsidiary of Vedanta Capital LLC). Mr. Saxena is also on the board of 18 other companies.

Mr. Saxena previously was President at Tie Tri-State, Product Manager at Becton, Dickinson & Co., Chairman at Tenzing Acquisition Corp., Chief Executive Officer of Invesco Private Capital, Inc., Principal at Chancellor Capital Management, Inc. and Principal at Booz Allen Hamilton, Inc.

Parag Phoolchand Saxena received a graduate degree from West Virginia University, an undergraduate degree from Indian Institute of Technology Bombay and an MBA from The Wharton School of the University of Pennsylvania.